ARTICLE | Company News
Theratechnologies other research news
April 29, 2002 7:00 AM UTC
Researchers published in Blood that PDT can selectively deplete host alloantigen-specific T cells to prevent GvHD, while preserving immune and anti-leukemia functions. In a mouse model of leukemia, an...